Cisplatin처리된 청각세포의 KCNE1 유전자에 의한 ROS 생성의 감쇠
Attenuation of ROS Generation by KCNE1 Genes in Cisplatin-treated Auditory Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Potassium is essential for the proper functioning of the ears. The inner ear's endolymph differs from all other extracellular fluids (in its positive potential) and in the ionic compositions in the various parts of the endolymphatic space. Ion concentration of the endolymph is 150 mM of potassium, which is comparable to the concentrations in other organs. Cisplatin (cis-diamminedichloroplatinum II: CDDP) is one of the most effective anticancer drugs, widely used against various tumors. However, its clinical use is limited by the onset of severe side effects, including ototoxicity and nephrotoxicity. For ototoxicity, a number of evidences in cytotoxic mechanism of cisplatin, including perturbation of redox status, increase in lipid peroxydation, and formation of DNA adduct, have been suggested. Therefore, in this study, the author investigated the relationship between the potassium ions on cisplatin-induced cytotoxicity in HEI-OC1 cells associated with reactive oxygen species (ROS). KCNE1 gene expression by the concentration of intracellular potassium appeared in the plasma membrane and increased the concentration of intracellular potassium. Cisplatin decreased the viability of HEI-OC1 cells, but the KCNE1 gene increased. Also, the KCNE1 gene significantly suppressed generation of intracellular ROS by cisplatin. Western blot analysis showed that the KCNE1 gene increased phase II detoxification enzymes markers such as superoxide dismutase 1 (SOD1), superoxide dismutase (SOD2), NAD(P)H:quinine oxidoreductases (NQO1), which were associated with the scavenger of ROS. These results suggest that the KCNE1 gene for intracellular potassium concentration ultimately prevents ROS generation from cisplatin and further contributes to protect auditory sensory hair cells from ROS produced by cisplatin.
Abstract
Potassium is essential for the proper functioning of the ears. The inner ear's endolymph differs from all other extracellular fluids (in its positive potential) and in the ionic compositions in the various parts of the endolymphatic space. Ion concentration of the endolymph is 150 mM of potassium, which is comparable to the concentrations in other organs. Cisplatin (cis-diamminedichloroplatinum II: CDDP) is one of the most effective anticancer drugs, widely used against various tumors. However, its clinical use is limited by the onset of severe side effects, including ototoxicity and nephrotoxicity. For ototoxicity, a number of evidences in cytotoxic mechanism of cisplatin, including perturbation of redox status, increase in lipid peroxydation, and formation of DNA adduct, have been suggested. Therefore, in this study, the author investigated the relationship between the potassium ions on cisplatin-induced cytotoxicity in HEI-OC1 cells associated with reactive oxygen species (ROS). KCNE1 gene expression by the concentration of intracellular potassium appeared in the plasma membrane and increased the concentration of intracellular potassium. Cisplatin decreased the viability of HEI-OC1 cells, but the KCNE1 gene increased. Also, the KCNE1 gene significantly suppressed generation of intracellular ROS by cisplatin. Western blot analysis showed that the KCNE1 gene increased phase II detoxification enzymes markers such as superoxide dismutase 1 (SOD1), superoxide dismutase (SOD2), NAD(P)H:quinine oxidoreductases (NQO1), which were associated with the scavenger of ROS. These results suggest that the KCNE1 gene for intracellular potassium concentration ultimately prevents ROS generation from cisplatin and further contributes to protect auditory sensory hair cells from ROS produced by cisplatin.
참고문헌 (25)
- Bortner CD, "A primary role for K+ and Na+ efflux in the activation of apoptosis", J Biol Chem, 272, pp.32436~32442 (1997)
- Boulikas T, "Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts", Oncol Rep, 12, pp.3~12 (2004)
- Fausti SA, "High-frequency monitoring for early detection of cisplatin ototoxicity", Arch Otolaryngol Head Neck Surg, 119, pp.661~666 (1993)
- FeghaliJG, "L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity", Laryngoscope, 111, pp.1147~1155 (2001)
- Hughes FM Jr, "Intracellular K+ suppresses the activation of apoptosis in lymphocytes", J Biol Chem, 272, pp.30567~30576 (1997)
- Jamieson ER, "Structure, recognition, and processing of cisplatin-DNA adducts", Chemical Reviews, 99, pp.2467~2498 (1999)
- Kalinec GM, "A cochlear cell line as an in vitro system for drug ototoxicity screening", Audiol Neurootol, 8, pp.177~189 (2003)
- Karki P, "Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release", Cell Death Differ, 14, pp.2068~2075 (2007)
- Kim HJ, "Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity", J Neurosci, 30, pp.3933~3946 (2010)
- Krick S, "Activation of K+ channels induces apoptosis in vascular smooth muscle cells", Amer J Physiol Cell Physiol, 280, pp.C970~C979 (2001)
- Madasu R, "Ototoxic effects of supradosecisplatin with sodium thiosulfate neutralization in patients with head and neck cancer", Arch Otolaryngol Head Neck Surg, 123, pp.978~981 (1997)
- Marklund L, "Cellular Potassium Ion Deprivation Enhances Apoptosis Induced by Cisplatin", Basic ClinPharmacolToxicol, 94, pp.245~251 (2004)
- Marklund L, "Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide", Int J Cancer, 93, pp.577~583 (2001)
- Rybak LP, "Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system", ToxicolSci, 47, pp.195~202 (1999)
- Rybak LP, "Ototoxicity: therapeutic opportunities", Drug Discov Today, 10, pp.1313~1321 (2005)
- Sastry J, "Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine", Pediatr Hematol Oncol, 22, pp.441~445 (2005)
- Sies H, "Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite", Advances in Pharmacology, 38, pp.229~246 (1997)
- So H, "Evidence that cisplatin-induced auditory damage is attenuated by downregulation of proinflammatory cytokines via Nrf2", HO-1, 2008, pp.9, 290~306
- So HS, "Flunarizine induces Nrf2-mediated transcriptional activation of hemeoxygenase- 1 in protection of auditory cells from cisplatin", Cell Death and Differentiation, 13, pp.1763~1775 (2006)
- Takeuchi S, "Ion channels inbasolateral membrane of marginal cells dissociated from gerbil striavascularis", Hear Res, 83, pp.89~100 (1995)
- Wang H, "Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader", Free Radic Biol Med, 27, pp.612~616 (1999)
- Wangemann P, "K+ cycling and the endocochlearpotential", Hear Res, 165, pp.1~9 (2002)
- Wangemann P, "The membrane potential of vestibular dark cells is controlled by a large Cl-conductance", Hear Res, 62, pp.149~156 (1992)
- Wasserman WW, "Functional antioxidant responsive elements", Proc Natl Acad Sci USA, 94, pp.5361~5366 (1997)
- Youn MJ, "Berberine, a Natural Product, Combined with Cisplatin Enhanced Apoptosis through a Mitochondria", Caspase-Mediated Pathway in HeLa Cells, 2008, pp.31, 789~795